[Biojava-dev] Java 1.5 (final chance to object)
    mark.schreiber at novartis.com 
    mark.schreiber at novartis.com
       
    Thu Oct  6 01:47:23 EDT 2005
    
    
  
Hello -
No one seemed to object to the idea of officially adopting java 1.5 for 
the biojava-live branch.
This would mean ...
biojava-live would require java1.5
generics, unboxing and other language features added in 1.5 will start to 
creep into the codebase.
all 'official' and 'preview' releases after biojava1.4 will require JDK1.5 
(Java 5).
If you plan to use new versions of biojava on a machine for which there is 
or will be no JDK1.5 then you should protest now!
- Mark
Mark Schreiber
Principal Scientist (Bioinformatics)
Novartis Institute for Tropical Diseases (NITD)
10 Biopolis Road
#05-01 Chromos
Singapore 138670
www.nitd.novartis.com
phone +65 6722 2973
fax  +65 6722 2910
    
    
More information about the biojava-dev
mailing list